CDC25A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.365400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.851600E-01
Normal-vs-Stage2
4.315200E-01
Normal-vs-Stage3
7.636000E-01
Normal-vs-Stage4
5.633200E-01
Stage1-vs-Stage2
9.483000E-01
Stage1-vs-Stage3
2.886600E-01
Stage1-vs-Stage4
9.765800E-01
Stage2-vs-Stage3
2.432400E-01
Stage2-vs-Stage4
9.237400E-01
Stage3-vs-Stage4
3.755000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.230000E-01
Normal-vs-AfricanAmerican
6.964800E-01
Normal-vs-Asian
3.895000E-01
Caucasian-vs-AfricanAmerican
4.492400E-01
Caucasian-vs-Asian
8.042000E-01
AfricanAmerican-vs-Asian
4.581400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.830600E-01
Normal-vs-Female
3.968400E-01
Male-vs-Female
2.435400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.984200E-01
Normal-vs-Age(41-60Yrs)
4.857000E-01
Normal-vs-Age(61-80Yrs)
4.102800E-01
Normal-vs-Age(81-100Yrs)
5.290600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.761200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.359200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.435600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.211400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.928600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.050400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.011200E-01
Normal-vs-Daily Drinker
3.843200E-01
Normal-vs-Weekly Drinker
3.896400E-01
Normal-vs-Occasional Drinker
3.232600E-01
Normal-vs-Social Drinker
4.575200E-01
Non Drinker-vs-Daily Drinker
7.217800E-01
Non Drinker-vs-Weekly Drinker
3.043400E-01
Non Drinker-vs-Occasional Drinker
9.851800E-01
Non Drinker-vs-Social Drinker
6.328200E-01
Daily Drinker-vs-Weekly Drinker
2.739600E-01
Daily Drinker-vs-Occasional Drinker
6.677800E-01
Daily Drinker-vs-Social Drinker
8.583200E-01
Weekly Drinker-vs-Occasional Drinker
3.736200E-01
Weekly Drinker-vs-Social Drinker
2.499000E-01
Occasional Drinker-vs-Social Drinker
5.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.010400E-01
Normal-vs-Grade 2
6.094200E-01
Normal-vs-Grade 3
6.228400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.717200E-01
Grade 1-vs-Grade 3
3.556600E-01
Grade 1-vs-Grade 4
6.010400E-01
Grade 2-vs-Grade 3
4.591400E-01
Grade 2-vs-Grade 4
6.094200E-01
Grade 3-vs-Grade 4
6.228400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.415000E-01
Normal-vs-NonDiabetic
4.247000E-01
Diabetic-vs-NonDiabetic
7.656200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.798800E-01
Normal-vs-NoPancreatitis
4.691800E-01
Pancreatitis-vs-NoPancreatitis
7.578600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.689800E-01
Normal-vs-N1
4.633800E-01
N0-vs-N1
6.928400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.869050E-01
Normal-vs-TP53-NonMutant
3.704800E-01
TP53-Mutant-vs-TP53-NonMutant
2.588000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
